Literature DB >> 9342441

Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats.

G G Page1, S Ben-Eliyahu.   

Abstract

We have previously reported sex- and estrous-related differences in host resistance to the metastatic development of a mammary adenocarcinoma cell line, MADB106, in the Fischer 344 (F344) rat. In other studies, we found that surgery suppressed natural killer (NK) cell activity and increased the NK-sensitive metastatic development of MADB106 tumor cells. The current study was designed to explore whether sex or estrous phase at the time of surgery impacts the degree of such deleterious effects of surgery. Such estrous effects could be related to an ongoing clinical debate regarding the importance of the timing of breast cancer surgery with the menstrual cycle in premenopausal women. Mature F344 males and cycling females underwent either experimental laparotomy with halothane anesthesia, halothane anesthesia alone, or were untreated. Five hours after surgery, animals either were injected with radiolabeled MADB106 tumor cells and assessed for lung tumor cell retention 12 hours later, or underwent blood withdrawal for in vitro assessment of NK cell activity. MADB106 tumor cells metastasize only to the lungs, and lung tumor cell retention is: a) an early indicator of the number of metastases that would develop weeks later, and b) highly sensitive to in vivo levels of NK activity. This mammary adenocarcinoma cell line is syngeneic to the inbred F344 strain of rats used in our studies, thus constituting a model for breast cancer metastasis. The results indicated that sex, estrous phase, and surgery interacted in their effects on NK cell activity and tumor metastasis. MADB106 lung tumor cell retention was increased by surgery in both sexes (2- to 3-fold) compared to the anesthesia only and control groups. This increase, however, was significantly greater in proestrus/estrus (P/E) females than in metestrus/diestrus (M/D) females. Among the control animals, females in P/E exhibited significantly less NK cytotoxic activity compared to the males, and the NK activity exhibited by females in M/D was between these two groups. Surgery suppressed NK cytotoxic activity to a similar level in all groups. Possible implications of these findings for the surgical care of women with breast cancer are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9342441     DOI: 10.1023/a:1005826403235

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Continuous stress disrupts immunostimulatory effects of IL-12.

Authors:  Ben Levi; Marganit Benish; Yael Goldfarb; Liat Sorski; Rivka Melamed; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-01-28       Impact factor: 7.217

2.  Male--female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement.

Authors:  Gayle G Page; Andrea M Fennelly; Marguerite T Littleton-Kearney; Shamgar Ben-Eliyahu
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

3.  Naringenin reduces lung metastasis in a breast cancer resection model.

Authors:  Lei Qin; Lingtao Jin; Linlin Lu; Xiaoyan Lu; Chunling Zhang; Fayun Zhang; Wei Liang
Journal:  Protein Cell       Date:  2011-07-12       Impact factor: 14.870

4.  Ethanol withdrawal hastens the aging of cytochrome c oxidase.

Authors:  Marianna E Jung; Xiaohua Ju; Daniel B Metzger; James W Simpkins
Journal:  Neurobiol Aging       Date:  2011-03-24       Impact factor: 4.673

5.  Salivary cortisol and soluble tumor necrosis factor-α receptor II responses to multiple experimental modalities of acute pain.

Authors:  Burel R Goodin; Noel B Quinn; Christopher D King; Gayle G Page; Jennifer A Haythornthwaite; Robert R Edwards; Laura Stapleton; Lynanne McGuire
Journal:  Psychophysiology       Date:  2011-09-06       Impact factor: 4.016

Review 6.  Exploiting the critical perioperative period to improve long-term cancer outcomes.

Authors:  Maya Horowitz; Elad Neeman; Eran Sharon; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

Review 7.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

8.  Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females.

Authors:  S Haim; G Shakhar; E Rossene; A N Taylor; S Ben-Eliyahu
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

9.  Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.

Authors:  S Ben-Eliyahu; G Shakhar; K Shakhar; R Melamed
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses.

Authors:  Marganit Benish; Shamgar Ben-Eliyahu
Journal:  Cancers (Basel)       Date:  2010-11-24       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.